Filing Details

Accession Number:
0001823239-24-000113
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-12 16:59:43
Reporting Period:
2024-11-11
Accepted Time:
2024-11-12 16:59:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1823239 Maravai Lifesciences Holdings Inc. MRVI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1205465 Carl Hull C/O Maravai Lifesciences Holdings, Inc.
10770 Wateridge Circle, Suite 200
San Diego CA 92121
See Remarks Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2024-11-11 175,000 $5.64 175,000 No 4 P Indirect Through The Hull Living Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Through The Hull Living Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class A Common Stock 35,000 Indirect Through Glossatori, LLC
Class A Common Stock 267,072 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.52 to $5.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.